Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 59

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 59
---
 Holders of our common stock have
no preference, conversion, exchange, sinking fund, redemption or appraisal rights and have no preemptive rights to subscribe for any of
our securities. Subject to the restrictions on ownership and transfer of stock contained in our charter and the terms of any other class
or series of stock, all our shares of common stock have equal dividend, liquidation and other rights.

Under the Maryland General Corporation Law (the
“MGCL”), a Maryland corporation generally cannot dissolve, amend its charter, merge, convert or consolidate with another entity,
sell all or substantially all of its assets or engage in a statutory share exchange, unless the action is advised by our board of directors
and approved by the affirmative vote of stockholders entitled to cast at least two-thirds of the votes entitled to be cast on the matter,
unless a lesser percentage (but not less than a majority) is specified in the corporation’s charter. Our charter provides that,
except for amendments to the provisions of our charter relating to (i) the removal of directors, (ii) the restrictions on ownership and
transfer of our capital stock and (iii) the vote required to amend such provisions (each of which requires the affirmative vote of stockholders
entitled to cast not less than two-thirds of all the votes to be cast on the matter) and certain amendments that require, pursuant to
the MGCL, only approval by our board of directors, these actions may be taken only if advised by our board of directors and approved by
the affirmative vote of stockholders entitled to cast a majority of all the votes entitled to be cast on the matter.

Listing. Our common stock is currently
listed on the NYSE under the symbol “GMRE.”

Transfer Agent and Registrar. The transfer
agent and registrar for our common stock is American Stock Transfer & Trust Company, LLC.

| 8 |

Description of Series A Preferred Stock

Our charter provides that we may issue up to 10,000,000
shares of preferred stock, $0.001 par value per share. 3,105,000 shares of preferred stock have been designated as shares of 7.50% Series
A Cumulative Redeemable Preferred Stock, par value $0.001 per share. As of February 26, 2024, there were 3,105,000 shares of our Series
A Preferred Stock issued and outstanding. Our charter authorizes the board of directors to amend our charter to increase or decrease the
aggregate number of authorized shares or the number